Stem Cell Homing: a Potential Therapeutic Strategy Unproven for Treatment of Myocardial Injury
- PMID: 30324254
- DOI: 10.1007/s12265-018-9823-z
Stem Cell Homing: a Potential Therapeutic Strategy Unproven for Treatment of Myocardial Injury
Abstract
Despite advances in the prevention and therapeutic modalities of ischemic heart disease, morbidity and mortality post-infarction heart failure remain big challenges in modern society. Stem cell therapy is emerging as a promising therapeutic strategy. Stem cell homing, the ability of stem cells to find their destination, is receiving more attention. Identification of specific cues and understanding the signaling pathways that direct stem cells to targeted destination will improve stem cell homing efficiency. This review discusses the cellular and molecular mechanism of stem cell homing at length in the light of literature and analyzes the problem and considerations of this approach as a treatment strategy for the treatment of ischemic heart disease clinically.
Keywords: Homing; Stem cell; Therapy.
Similar articles
-
Epicardial delivery of VEGF and cardiac stem cells guided by 3-dimensional PLLA mat enhancing cardiac regeneration and angiogenesis in acute myocardial infarction.J Control Release. 2015 May 10;205:218-30. doi: 10.1016/j.jconrel.2015.02.013. Epub 2015 Feb 11. J Control Release. 2015. PMID: 25681051
-
Stem cell therapy for acute myocardial infarction: on the horizon or still a dream?Coron Artery Dis. 2018 Mar;29(2):89-91. doi: 10.1097/MCA.0000000000000589. Coron Artery Dis. 2018. PMID: 29140809 Free PMC article. No abstract available.
-
Mending a Faltering Heart.Circ Res. 2016 Jan 22;118(2):344-51. doi: 10.1161/CIRCRESAHA.115.306820. Circ Res. 2016. PMID: 26838318 Review.
-
Myocardial infarction: stem cell transplantation for cardiac regeneration.Regen Med. 2015 Nov;10(8):1025-43. doi: 10.2217/rme.15.63. Epub 2015 Nov 13. Regen Med. 2015. PMID: 26563414 Review.
-
SDF-1α as a therapeutic stem cell homing factor in myocardial infarction.Pharmacol Ther. 2011 Jan;129(1):97-108. doi: 10.1016/j.pharmthera.2010.09.011. Epub 2010 Oct 20. Pharmacol Ther. 2011. PMID: 20965212 Review.
Cited by
-
Targeted Therapy of Acute Liver Injury via Cryptotanshinone-Loaded Biomimetic Nanoparticles Derived from Mesenchymal Stromal Cells Driven by Homing.Pharmaceutics. 2023 Dec 12;15(12):2764. doi: 10.3390/pharmaceutics15122764. Pharmaceutics. 2023. PMID: 38140104 Free PMC article.
-
CSF2RB overexpression promotes the protective effects of mesenchymal stromal cells against ischemic heart injury.Theranostics. 2023 Mar 13;13(6):1759-1773. doi: 10.7150/thno.81336. eCollection 2023. Theranostics. 2023. PMID: 37064880 Free PMC article.
-
Cell-derived membrane biomimetic nanocarriers for targeted therapy of pulmonary disease.Int J Pharm. 2022 May 25;620:121757. doi: 10.1016/j.ijpharm.2022.121757. Epub 2022 Apr 18. Int J Pharm. 2022. PMID: 35447225 Free PMC article. Review.
-
Regenerative Medicine for the Treatment of Ischemic Heart Disease; Status and Future Perspectives.Front Cell Dev Biol. 2021 Sep 10;9:704903. doi: 10.3389/fcell.2021.704903. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34568321 Free PMC article. Review.
-
Specific Blood Cells Derived from Pluripotent Stem Cells: An Emerging Field with Great Potential in Clinical Cell Therapy.Stem Cells Int. 2021 Aug 11;2021:9919422. doi: 10.1155/2021/9919422. eCollection 2021. Stem Cells Int. 2021. PMID: 34434242 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
